GLucoRx and Cardiff University are set to launch the world's first non-invasive continuous glucose monitor (CGM)
Using a radio frequency technology alongside a multiple sensor approach, the GlucoRx BioXensor effectively blood glucose levels every minute.
Today approximately 422 million people around the globe have diabetes according to World Health Organisation.
Currently, people with diabetes uses the glucometers and must prick their finger to extract their blood several times a day. Another method is to apply semi-invasive devices such as continuous blood glucose monitors (CGMs)
Ranging from the monitoring from 3 mmol/l to 30mmol/l the GlucoRx BioXensor now provides people with an alternative to blood glucose monitoring for the first time.
The small and discreet wearable multi-sensor device weighs 14g and is 42mm in diameter by 7mm. It was developed in collaboration with Professor Adrian Porch and Dr Heungjae Choi, who are both experts in radio frequency technology from Cardiff University’s School of Engineering.
Preventing the onset of diabetes, or its remission, the GlucoRx BioXensoimproving will improve quality of life qith its smart alarms and remote monitoring technology.
“We are exciting about this life-changing end-to-end diabetes monitoring platform of ours which can be discreetly stuck on the skin to monitor blood glucose, giving readings every minute on smart mobile applications.
“GlucoRx BioXensor has standout accuracy with a proven MARD of 10.4%, owing to its multi sensor approach capturing blood glucose as well as Sp02, ECG, respiration rate, heart rate, temperature, activity, sleep, and early fall detection. The wearable device has a longer shelf-life because it is not chemical in its action.” Chris Chapman, GlucoRx chief operating officer said.
The team is said to conduct a further pivotal clinical study later this year on its smaller and improved fourth generation device before submitting CE certification following a series of successful trials at Swansea University with Professor Stephen Luzio.